Which statement accurately describes the immunosuppressive properties of NSAIDs compared with glucocorticoids?

Which statement accurately describes the immunosuppressive properties of NSAIDs compared with glucocorticoids?

• A. NSAIDs are not immunosuppressive, whereas glucocorticoids are immunosuppressive.
• B. NSAIDs have faster onset of action than glucocorticoids.
• C. NSAIDs are controlled substances but glucocorticoids are not.
• D. NSAIDs may be used topically, but glucocorticoids are not effective topically.

Answer: (A)

NSAIDs do not suppress the immune system; glucocorticoids do. The key difference is how they affect inflammation and immune function. NSAIDs block enzymes (COX-1 and COX-2) involved in making prostaglandins, which reduces pain, fever, and swelling. This dampens inflammatory signs but doesn’t broadly dampen immune cell activity or cytokine production. Glucocorticoids enter cells and alter gene transcription, leading to widespread suppression of immune responses: they reduce cytokines like IL-2 and TNF-alpha, inhibit T-cell activation, and impair macrophage and other immune cell functions. That broad, systemic immunosuppression is why glucocorticoids are used for suppression of immune-related conditions, whereas NSAIDs are not immunosuppressive in the same sense. The other statements don’t describe this fundamental difference. Onset timing can vary for different effects and isn’t the defining distinction for immunosuppression. The notion that NSAIDs are controlled substances while glucocorticoids are not isn’t a reliable general rule. And topical effectiveness exists for corticosteroids, so claiming they aren’t effective topically isn’t accurate.

NSAIDs do not suppress the immune system; glucocorticoids do. The key difference is how they affect inflammation and immune function. NSAIDs block enzymes (COX-1 and COX-2) involved in making prostaglandins, which reduces pain, fever, and swelling. This dampens inflammatory signs but doesn’t broadly dampen immune cell activity or cytokine production. Glucocorticoids enter cells and alter gene transcription, leading to widespread suppression of immune responses: they reduce cytokines like IL-2 and TNF-alpha, inhibit T-cell activation, and impair macrophage and other immune cell functions. That broad, systemic immunosuppression is why glucocorticoids are used for suppression of immune-related conditions, whereas NSAIDs are not immunosuppressive in the same sense.

The other statements don’t describe this fundamental difference. Onset timing can vary for different effects and isn’t the defining distinction for immunosuppression. The notion that NSAIDs are controlled substances while glucocorticoids are not isn’t a reliable general rule. And topical effectiveness exists for corticosteroids, so claiming they aren’t effective topically isn’t accurate.